Researchers from Rutgers Robert Wood Johnson Medical School’s Department of Neurology have traced a previously observed link between microscopic organisms in the digestive tract—collectively known as the gut microbiome—and multiple sclerosis (MS). Their study in genetically altered mice and people…
Read MoreWhy a healthy lifestyle is not enough to prevent dementia
Dementia is on the rise in Germany. In the absence of treatment options, the focus is shifting to preventing dementia. In particular, a healthy lifestyle is considered beneficial for brain health. A study by the Faculty of Medicine now shows…
Read MoreGenetic testing program could help to close the gap for some patients with prostate cancer
Some patients with prostate cancer have genetic mutations that may impact their treatment. A comprehensive, on-site genetic testing program, pioneered by urologists, could help to close the gap for this underutilized resource, reports a study in Urology Practice®, an Official…
Read MoreAs viral infections skyrocket, masks are still a tried-and-true way to help keep yourself and others safe
The cold and flu season of 2022 has begun with a vengeance. Viruses that have been unusually scarce over the past three years are reappearing at remarkably high levels, sparking a “tripledemic” of COVID-19, the flu and respiratory syncytial virus,…
Read MoreBeta-thalassemia: Benefits of Gene Therapy Outweigh Costs
Nearly 90% of beta-thalassemia patients were transfusion free for up to 8 years after treatment with the one-time gene therapy betibeglogene autotemcel (beti-cel), according to a report at the American Society of Hematology annual meeting. Surveyed at 3 years, patients also reported…
Read MoreFewer patients diagnosed with cancer in early stages during pandemic
Britain’s cancer crisis laid bare: Nearly HALF of all cases aren’t diagnosed until they have spread – when survival rates are much lower, NHS data shows Almost half of cancers are being diagnosed in the later stages, a report revealed…
Read MoreITP: Biologic Beat Placebo, but Few Patients Improved
NEW ORLEANS – Patients with chronic immune thrombocytopenia (ITP) fared better on intravenous efgartigimod (Vyvgart) than a placebo, a new study found. Still, only 21.8% of subjects who received the biologic reached the primary endpoint of sustained platelet count response, an indication…
Read MoreTracking plasma cell survival in the bone marrow and spleen
Just as a fire department mobilizes in response to a reported fire, specialized immune cells in the body mobilize in response to the introduction of foreign substances known as antigens. Plasma cells are an important type of immune cell that…
Read MoreWhat are anxiety rings, and how do they work?
Anxiety rings are everywhere on TikTok, but do they actually work? We asked an expert to explain. Feeling anxious is never ideal, but it’s especially difficult when you’re in the middle of something, like your morning commute or a meeting…
Read MoreSleep better – humans should go through ‘4 sleep phases’, says expert
Stacey Solomon gets tips and advice from sleep expert We use your sign-up to provide content in ways you’ve consented to and to improve our understanding of you. This may include adverts from us and 3rd parties based on our…
Read More